Company intelligence / Profile preview

CordenPharma

Liestal, Basel-Landschaft, Switzerlandcordenpharma.com ↗

Ownership: Private
Employees: ~2600
Development stage: Commercial

Overview

CordenPharma does not have its own clinical pipeline or results. It provides contract development and manufacturing services across all phases of drug development from pre-clinical to commercial supply for global pharma and biotech customers. The company has recently expanded peptide production capacity with major investments in Switzerland and the US to meet growing demand for innovative peptide medicines.

Modalities: PeptidesOligonucleotidesLipidsSmall moleculeHighly potent active pharmaceutical ingredients (HPAPIs)Injectables
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on CordenPharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CordenPharma.

Explore the full profile